Cigna Group (NYSE: CI) EVP sells 19,436 shares after option exercise

Rhea-AI Filing Summary

The Cigna Group executive Nicole S. Jones, EVP and Chief Administrative and Chief Human Resources Officer, exercised 15,346 employee stock options at $192.02 per share on August 4–5, 2026, receiving common stock.

She also sold 19,436 common shares at $276.27 per share on August 4, 2026. All trades were made under a Rule 10b5-1 trading plan adopted May 4, 2026. As of August 4, 2026, she reported 1,451.2364 shares held indirectly through The Cigna Group's 401(k) Plan.

Insider Trade Summary 10b5-1

Exercise and sale activity reported; no spread calculated

Exercise and Sale 6 txns

Insider Jones Nicole S

Role See Remarks

Sold 19,436 shs ($5.37M)

Approx. gross sale proceeds $5.37M

Approx. exercise cost $2.95M

Type	Security	Shares	Price	Value
Exercise	Employee Stock Option (Right to Buy) F1, F3	1,301	$0.00	$0.00
Exercise	Common Stock, $.01 Par Value F1	1,301	$192.02	$250K
Exercise	Employee Stock Option (Right to Buy) F1, F3	14,045	$0.00	$0.00
Exercise	Common Stock, $.01 Par Value F1	14,045	$192.02	$2.70M
Sale	Common Stock, $.01 Par Value F1	19,436	$276.27	$5.37M
holding	Common Stock, $.01 Par Value F2	--	--	--

Holdings After Transaction: Employee Stock Option (Right to Buy) — 0 shares (Direct); Common Stock, $.01 Par Value — 28,557 shares (Direct); Common Stock, $.01 Par Value — 1,451.2364 shares (Indirect, By 401(k))

Footnotes (3)

1. F1. These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 4, 2026.
2. F2. Represents shares acquired through ongoing participation in The Cigna Group's 401(k) Plan.
3. F3. This option was granted on February 26, 2020. The option vested in three equal annual installments on the first, second and third anniversaries of the grant date.

Key Figures

Shares sold: 19,436 shares Sale price: $276.2700 per share Options exercised: 15,346 shares +3 more

6 metrics

Shares sold 19,436 shares Common stock sold on August 4, 2026 at $276.2700 per share

Sale price $276.2700 per share Price per share for the 19,436-share common stock sale on August 4, 2026

Options exercised 15,346 shares Total employee stock options exercised on August 4–5, 2026

Exercise price $192.0200 per share Exercise price of employee stock options granted February 26, 2020

401(k) holdings 1,451.2364 shares Indirect common stock holdings in The Cigna Group's 401(k) Plan as of August 4, 2026

Option expiration date 2030-02-26 Expiration date of employee stock options exercised in these transactions

Key Terms

Rule 10b5-1 trading plan, Employee Stock Option (Right to Buy), 401(k) Plan

3 terms

Rule 10b5-1 trading plan regulatory

"These transactions were effected pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

Employee Stock Option (Right to Buy) financial

"security_title: Employee Stock Option (Right to Buy)"

401(k) Plan financial

"ongoing participation in The Cigna Group's 401(k) Plan"

A 401(k) plan is a workplace retirement account that lets employees set aside part of their pay into a tax-advantaged savings pot, often with employers adding matching contributions — like a workplace piggy bank for future income. It matters to investors because the amount people save and how employers fund these plans influence consumer spending, corporate payroll costs and the flow of money into financial markets, which can affect stock prices and company valuations.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/06/2026 - 04:32 PM Accepted by SEC EDGAR 08/06/2026 - 04:31 PM Learn about SEC filing dates

FAQ

What insider transactions did Cigna Group (CI) EVP Nicole S. Jones report?

Nicole S. Jones reported exercising 15,346 employee stock options at $192.02 per share on August 4–5, 2026 and selling 19,436 Cigna Group common shares at $276.27 per share on August 4, 2026, all pursuant to a Rule 10b5-1 trading plan.

How many Cigna Group (CI) shares did Nicole S. Jones sell and at what price?

She sold 19,436 Cigna Group common shares on August 4, 2026 at a price of $276.27 per share. The sale was reported as a disposition of directly owned shares and was executed under a Rule 10b5-1 trading plan adopted May 4, 2026.

How many Cigna Group (CI) employee stock options did Nicole S. Jones exercise?

She exercised a total of 15,346 employee stock options at an exercise price of $192.02 per share on August 4 and 5, 2026. These options were originally granted on February 26, 2020 and vested in three equal annual installments, according to the reported footnote.

Were Nicole S. Jones’s Cigna Group (CI) trades made under a Rule 10b5-1 plan?

Yes. The filing notes that the reported option exercises and share sale were effected pursuant to a Rule 10b5-1 trading plan adopted by Nicole S. Jones on May 4, 2026. The document-level Rule 10b5-1 checkbox is also affirmed as selected for these transactions.

What Cigna Group (CI) shares does Nicole S. Jones hold through the 401(k) Plan?

As of August 4, 2026, she reported 1,451.2364 Cigna Group common shares held indirectly through ongoing participation in The Cigna Group's 401(k) Plan. This holding entry is separate from her directly held shares involved in the option exercises and sale.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Jones Nicole S

(Last) (First) (Middle)

900 COTTAGE GROVE ROAD

(Street)

BLOOMFIELD CONNECTICUT 06002

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Cigna Group [ CI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $.01 Par Value	08/04/2026		M(1)		14,045	A	$192.02	46,692	D
Common Stock, $.01 Par Value	08/04/2026		S(1)		19,436	D	$276.27	27,256	D
Common Stock, $.01 Par Value	08/05/2026		M(1)		1,301	A	$192.02	28,557	D
Common Stock, $.01 Par Value								1,451.2364(2)	I	By 401(k)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	$192.02	08/04/2026		M(1)			14,045	02/26/2021(3)	02/26/2030	Common Stock, $.01 Par Value	14,045	$0	1,301	D
Employee Stock Option (Right to Buy)	$192.02	08/05/2026		M(1)			1,301	02/26/2021(3)	02/26/2030	Common Stock, $.01 Par Value	1,301	$0	0	D

Explanation of Responses:

1. These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 4, 2026.

2. Represents shares acquired through ongoing participation in The Cigna Group's 401(k) Plan.

3. This option was granted on February 26, 2020. The option vested in three equal annual installments on the first, second and third anniversaries of the grant date.

Remarks:

EVP, Chief Administrative Officer and Chief Human Resources Officer

	Tyler Gratton, attorney-in-fact	08/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)